These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets. Mendes RE; Castanheira M; Woosley LN; Stone GG; Bradford PA; Flamm RK Int J Antimicrob Agents; 2018 Aug; 52(2):287-292. PubMed ID: 29654893 [TBL] [Abstract][Full Text] [Related]
5. Carbapenem-resistant Klebsiella pneumoniae vertebral osteomyelitis in a renal transplant recipient treated with ceftazidime-avibactam. Cani E; Moussavi F; Ocheretyaner E; Sharma R; Brown C; Eilertson B Transpl Infect Dis; 2018 Apr; 20(2):e12837. PubMed ID: 29359842 [TBL] [Abstract][Full Text] [Related]
6. The antibiotic arms race: current and emerging therapy for Plazak ME; Tamma PD; Heil EL Expert Opin Pharmacother; 2018 Dec; 19(18):2019-2031. PubMed ID: 30346216 [No Abstract] [Full Text] [Related]
7. Successful Treatment of Pandrug-resistant Klebsiella pneumoniae Infection With Ceftazidime-avibactam in a Preterm Infant: A Case Report. Coskun Y; Atici S Pediatr Infect Dis J; 2020 Sep; 39(9):854-856. PubMed ID: 32804464 [TBL] [Abstract][Full Text] [Related]
8. Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections. Falcone M; Paterson D J Antimicrob Chemother; 2016 Oct; 71(10):2713-22. PubMed ID: 27432599 [TBL] [Abstract][Full Text] [Related]
10. First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate. Humphries RM; Yang S; Hemarajata P; Ward KW; Hindler JA; Miller SA; Gregson A Antimicrob Agents Chemother; 2015 Oct; 59(10):6605-7. PubMed ID: 26195508 [TBL] [Abstract][Full Text] [Related]
11. KPC-producing Klebsiella pneumoniae gut decolonisation following ceftazidime/avibactam-based combination therapy: A retrospective observational study. Bassetti M; Carannante N; Pallotto C; Righi E; Di Caprio G; Bernardo M; Sodano G; Mallardo E; Francisci D; Sartor A; Graziano E; Tascini C J Glob Antimicrob Resist; 2019 Jun; 17():109-111. PubMed ID: 30468915 [TBL] [Abstract][Full Text] [Related]
12. Combination treatment with extended-infusion ceftazidime/avibactam for a KPC-3-producing Klebsiella pneumoniae bacteraemia in a kidney and pancreas transplant patient. Jacobs DM; DiTursi S; Ruh C; Sharma R; Claus J; Banjade R; Rao GG Int J Antimicrob Agents; 2016 Aug; 48(2):225-7. PubMed ID: 27396948 [No Abstract] [Full Text] [Related]
13. Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment. Galani I; Karaiskos I; Angelidis E; Papoutsaki V; Galani L; Souli M; Antoniadou A; Giamarellou H Eur J Clin Microbiol Infect Dis; 2021 Jan; 40(1):219-224. PubMed ID: 32729059 [TBL] [Abstract][Full Text] [Related]
14. Ceftazidime-avibactam in the treatment of infections caused by KPC-producing Klebsiella pneumoniae: factors associated with clinical efficacy in a single-center cohort. Castón JJ; Gallo M; García M; Cano A; Escribano A; Machuca I; Gracia-Aufinger I; Guzman-Puche J; Pérez-Nadales E; Recio M; Muñoz M; Martínez-Martínez L; Torre-Cisneros J; Int J Antimicrob Agents; 2020 Sep; 56(3):106075. PubMed ID: 32629116 [TBL] [Abstract][Full Text] [Related]
15. Cure of recurring Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae septic shock episodes due to complicated soft tissue infection using a ceftazidime and avibactam-based regimen: a case report. Parruti G; Frattari A; Polilli E; Savini V; Sciacca A; Consorte A; Cibelli DC; Agostinone A; Di Masi F; Pieri A; Cacciatore P; Di Iorio G; Fazii P; Spina T J Med Case Rep; 2019 Jan; 13(1):20. PubMed ID: 30665450 [TBL] [Abstract][Full Text] [Related]
16. A challenging case of carbapenemase-producing Klebsiella pneumoniae septic thrombophlebitis and right mural endocarditis successfully treated with ceftazidime/avibactam. Iacovelli A; Spaziante M; Al Moghazi S; Giordano A; Ceccarelli G; Venditti M Infection; 2018 Oct; 46(5):721-724. PubMed ID: 29926399 [TBL] [Abstract][Full Text] [Related]
17. First case of ceftazidime/avibactam administration in home care. ESBL producing Klebsiella pneumoniae bacteremia. Torres-Del-Pliego E; Delgado-Mejía E; Gil-Alonso L; Del Mar-Periáñez-Párraga L Enferm Infecc Microbiol Clin; 2017 May; 35(5):322-323. PubMed ID: 27712848 [No Abstract] [Full Text] [Related]
18. Use of Ceftazidime-avibactam for the Treatment of Extensively drug-resistant or Pan drug-resistant Klebsiella pneumoniae in Neonates and Children <5 Years of Age. Iosifidis E; Chorafa E; Agakidou E; Kontou A; Violaki A; Volakli E; Christou EI; Zarras C; Drossou-Agakidou V; Sdougka M; Roilides E Pediatr Infect Dis J; 2019 Aug; 38(8):812-815. PubMed ID: 31135647 [TBL] [Abstract][Full Text] [Related]